HCM II Acquisition Corp. (NASDAQ:HOND - Get Free Report)'s share price reached a new 52-week high during trading on Friday . The company traded as high as $18.18 and last traded at $17.61, with a volume of 603525 shares. The stock had previously closed at $16.88.
Analysts Set New Price Targets
Separately, Weiss Ratings restated a "sell (d-)" rating on shares of HCM II Acquisition in a report on Saturday, September 27th.
View Our Latest Stock Report on HCM II Acquisition
HCM II Acquisition Stock Performance
The business has a 50-day moving average of $12.36 and a two-hundred day moving average of $11.48.
Institutional Investors Weigh In On HCM II Acquisition
A number of institutional investors have recently added to or reduced their stakes in HOND. Linden Advisors LP acquired a new stake in shares of HCM II Acquisition in the 1st quarter valued at $21,150,000. Magnetar Financial LLC acquired a new stake in HCM II Acquisition during the 1st quarter valued at $20,719,000. MMCAP International Inc. SPC acquired a new position in HCM II Acquisition in the first quarter worth $10,310,000. Encompass Capital Advisors LLC bought a new stake in shares of HCM II Acquisition during the first quarter worth $10,006,000. Finally, Shay Capital LLC acquired a new stake in HCM II Acquisition in the 2nd quarter valued at about $6,086,000.
HCM II Acquisition Company Profile
(
Get Free Report)
HCM II Acquisition Corp. operates as a blank check company. It was formed for the purpose of entering into a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on April 4, 2024 and is headquartered in Stamford, CT.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider HCM II Acquisition, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCM II Acquisition wasn't on the list.
While HCM II Acquisition currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.